-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Scientific Symposia on COVID-19 Vaccination in Immunocompromised Patients - Live Q&A

PhD Trainee
Program: Scientific Symposia
Hematology Disease Topics & Pathways:
Translational Research, Immune Mechanism, Diseases, SARS-CoV-2/COVID-19, Infectious Diseases, Multi-Systemic Interactions, Biological Processes
Sunday, December 12, 2021: 9:30 AM-10:15 AM
Hall C2-C3 (Georgia World Congress Center)
Co-chairs:
Amit Verma, MD, Albert Einstein College of Medicine, Montefiore Medical Center and Sabine Eichinger, MD, Medical University of Vienna, Medical University of Vienna
Disclosures:
Verma: Acceleron: Consultancy; Novartis: Consultancy; Stelexis: Consultancy, Current equity holder in publicly-traded company; Eli Lilly: Research Funding; Curis: Research Funding; Medpacto: Research Funding; Incyte: Research Funding; GSK: Research Funding; BMS: Research Funding; Celgene: Consultancy; Stelexis: Current equity holder in publicly-traded company; Throws Exception: Current equity holder in publicly-traded company. Eichinger: CSL Behring: Speakers Bureau; Takeda: Speakers Bureau; Boehringer-Ingelheim: Speakers Bureau; Pfizer: Speakers Bureau; BMS: Speakers Bureau; Bayer: Speakers Bureau; Daiichi-Sankyo: Speakers Bureau.
Panelists:
Sean Hua Lim, MD, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton General Hospital , Nina Haagenrud Haagenrud Schultz, MD, PhD, Oslo University Hospital, Oslo University Hospital and Gwen L Nichols, MD, The Leukemia & Lymphoma Society
Disclosures:
Lim: Roche: Honoraria; Xcella: Consultancy; Celldex Therapeutics: Membership on an entity's Board of Directors or advisory committees, Research Funding; N/A: Patents & Royalties: Patent Pending: Co-inventor: Anti-CD27 enhanced therapy (UK Patent Application No. 1613167.4; Bioinvent International: Research Funding. Schultz: Bristol Myers Squibb: Honoraria; Bayer: Honoraria; Pfizer: Honoraria.
See more of: Scientific Symposia